Table 3. Baseline characteristics of study groups.
| Parameter | NCR (control) | CR | P value |
|---|---|---|---|
| No. (male/female) | 213 (159 /54) | 111 (74/37) | 0.13 |
| Age | 57.67 ± 7.99 | 55.82 ± 9.31 | 0.062 |
| BMI | 28.71 ± 4.23 | 29.42 ± 4.74 | 0.170 |
| Cholesterol (mg/dl) | 288.00 ± 9.64 | 290.67 ± 10.75 | 0.023 |
| TG | 240.79 ± 18.63 | 238.51 ± 19.45 | 0.299 |
| VLDL | 48.15 ± 3.67 | 47.70 ± 3.89 | 0.305 |
| LDL | 207.39 ± 11.53 | 210.43 ± 13.20 | 0.033 |
| HDL | 32.45 ± 3.19 | 32.54 ± 3.46 | 0.815 |
| Platelet count (×103/mm3) | 240.41 ± 49.62 | 249.21± 67.33 | 0.182 |
| KDR (pg/ml) | 8075 ± 687 | 8098± 731 | 0.779 |
| Diseased vessels | 157 | 90 | 0.569 |
| HT | 192 | 102 | 0.90 |
| DM | 119 | 60 | 0.86 |
| Smoker | 103 | 62 | 0.46 |
| CCBs | 37 | 22 | 0.653 |
| ACEI/ARBs | 51 | 35 | 0.268 |
| B-Blockers | 131 | 70 | 0.894 |
| Diuretics | 64 | 38 | 0.580 |
| PPI | 33 | 26 | 0.150 |
| Nitrates | 104 | 59 | 0.672 |